Auspherix's Series A - II Round

Auspherix raised a round of funding on October 23, 2014. Investors include Medical Research Commercialisation Fund.

Auspherix has discovered a brand new class of antibacterials with a unique profile and novel mechanism of action that could overcome rising problems of resistance to current antibiotics. Its compound …

Articles about Auspherix's Series A - II Round: